THNR ETF

THNR ETF
$25.76
See how much of THNR you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

LLY is THNR's largest holding at 11.95% of the fund as of Nov 1, 2026. THNR is Amplify Weight Loss Drug & Treatment ETF.

Showing top 22 of 22 holdings · as of Nov 1, 2026
THNR holdings, by weight
#TickerNameWeightCumulativeSharesMkt valueSectorIndustry
1
LLY
Eli Lilly & CoHealth Care · Pharmaceuticals
11.95%
11.9%503$713.0KHealth CarePharmaceuticals
2—Novo-Nordisk A/S-Spons AdrHealth Care · Pharmaceuticals
8.60%
20.5%12,835$513.4KHealth CarePharmaceuticals
Sector and industry · Pro
3
AMGN
Amgen Inc.
6.15%
26.7%788$367.2K
4
REGN
Regeneron Pharmaceuticals Inc
5.91%
32.6%380$352.6K
5—AstraZeneca PLC
5.91%
38.5%1,888$352.4K
6—Roche Holding Ag- Genusschein
5.81%
44.3%708$347.0K
7
GILD
Gilead Sciences Inc
5.79%
50.1%2,024$345.5K
8
ABBV
AbbVie Inc.
5.68%
55.8%1,149$338.8K
9
PFE
Pfizer Inc
5.57%
61.4%10,896$332.5K
10—Chugai Pharmaceutical Co. Ltd. Com Stk
5.08%
66.5%7,000$303.2K
11
MRK
Merck & Company Inc
5.07%
71.5%2,025$302.8K
12—CSPC Pharmaceutical Group Limited Shs
4.40%
75.9%262,000$262.7K
13
VKTX
Viking Therapeutics Inc
4.17%
80.1%9,118$248.7K
14—Innovent Biologics Inc
4.17%
84.3%24,500$249.1K
15
ARWR
Arrowhead Pharmaceuticals Inc
3.55%
87.8%3,541$212.1K
16
ZEAL
Zealand Pharma AS
3.25%
91.1%5,542$193.8K
17—Hanmi Pharm Co Ltd
2.88%
93.9%552$171.7K
18—Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H
2.32%
96.3%21,400$138.3K
19—Structure Therapeutics Inc Adr
2.23%
98.5%6,098$133.4K
20
KLRA
Kailera Therapeutics Inc
1.07%
99.6%4,979$64.0K
21
AGPXX
Invesco Government & Agency Portfolio, Institutional Class
0.24%
99.8%14,559$14.6K
22—Other Assets and Liabilities
0.18%
100.0%281,840,188$10.5K
Not reported for this fund: share changes.
FundXLS Pro
See every sector, industry and share-change value
X-ray every fund you own at once, ETFs and mutual funds that hold stocks directly, and see how much of your money lands on the same stocks twice.
Unlock FundXLS Pro$45/quarter Pro · Cancel anytime

THNR ETF All Holdings

THNR holdings total 22 positions. The top 10 holdings account for 66.5% of the fund, led by Eli Lilly & Co at 11.9%, Novo-Nordisk A/S-Spons Adr at 8.6%, Amgen Inc. at 6.2%.

THNR portfolio concentration is relatively high, with the top 10 representing 66.5% of total assets. The largest sector exposure is Health Care at 73.2%.

THNR sectors provide a detailed breakdown. THNR overlap shows how holdings compare to other funds in your portfolio.

THNR ETF Holdings

22 of 22 holdings

  • 1

    Eli Lilly & Co

    LLYHealth Care
    11.95%
  • 2

    Novo-Nordisk A/S-Spons Adr

    NVO:OSHealth Care
    8.60%
  • 3

    Amgen Inc.

    AMGNHealth Care
    6.15%
  • 4

    Regeneron Pharmaceuticals Inc

    REGNHealth Care
    5.91%
  • 5

    AstraZeneca PLC

    AZN:LNUnknown
    5.91%
  • 6

    Roche Holding Ag- Genusschein

    RHO5:FFUnknown
    5.81%
  • 7

    Gilead Sciences Inc

    GILDHealth Care
    5.79%
  • 8

    Abbvie Inc.

    ABBVHealth Care
    5.68%
  • 9

    Pfizer Inc

    PFEHealth Care
    5.57%
  • 10

    Chugai Pharmaceutical Co. Ltd. Com Stk

    4519:JPUnknown
    5.08%
  • 11

    Merck & Company Inc

    MRKHealth Care
    5.07%
  • 12

    CSPC Pharmaceutical Group Limited Shs

    1093:HKHealth Care
    4.40%
  • 13

    Viking Therapeutics Inc

    VKTXHealth Care
    4.17%
  • 14

    Innovent Biologics Inc

    1801:HKHealth Care
    4.17%
  • 15

    Arrowhead Pharmaceuticals Inc

    ARWRHealth Care
    3.55%
  • 16

    Zealand Pharma AS

    ZEAL:COUnknown
    3.25%
  • 17

    Hanmi Pharm Co Ltd

    128940:KRUnknown
    2.88%
  • 18

    Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H

    1276:SHUnknown
    2.32%
  • 19

    Structure Therapeutics Inc Adr

    GPCR:SHHealth Care
    2.23%
  • 20

    Kailera Therapeutics Inc

    KLRAUnknown
    1.07%
  • 21

    Invesco Government & Agency Portfolio, Institutional Class

    AGPXXFinancials
    0.24%
  • 22

    Other Assets And Liabilities

    Other
    0.18%